Table of Contents 1 Small Molecule Active Pharmaceutical Ingredient Market Overview 1.1 Small Molecule Active Pharmaceutical Ingredient Product Overview 1.2 Small Molecule Active Pharmaceutical Ingredient Market Segment by Type 1.2.1 Standard API 1.2.2 High Potency API 1.3 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Type 1.3.1 Global Small Molecule Active Pharmaceutical Ingredient Sales and Growth by Type 1.3.2 Global Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Type (2014-2019) 1.3.3 Global Small Molecule Active Pharmaceutical Ingredient Revenue and Market Share by Type (2014-2019) 1.3.4 Global Small Molecule Active Pharmaceutical Ingredient Price by Type (2014-2019) 2 Global Small Molecule Active Pharmaceutical Ingredient Market Competition by Company 2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Company (2014-2019) 2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue and Share by Company (2014-2019) 2.3 Global Small Molecule Active Pharmaceutical Ingredient Price by Company (2014-2019) 2.4 Global Top Players Small Molecule Active Pharmaceutical Ingredient Manufacturing Base Distribution, Sales Area, Product Types 2.5 Small Molecule Active Pharmaceutical Ingredient Market Competitive Situation and Trends 2.5.1 Small Molecule Active Pharmaceutical Ingredient Market Concentration Rate 2.5.2 Global Small Molecule Active Pharmaceutical Ingredient Market Share of Top 5 and Top 10 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Small Molecule Active Pharmaceutical Ingredient Company Profiles and Sales Data 3.1 Johnson Matthey 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification 3.1.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin(2014-2019) 3.1.4 Main Business Overview 3.2 Siegfried Holding AG 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification 3.2.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin(2014-2019) 3.2.4 Main Business Overview 3.3 Pfizer 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification 3.3.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin(2014-2019) 3.3.4 Main Business Overview 3.4 Sanofi S.A. 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification 3.4.3 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin(2014-2019) 3.4.4 Main Business Overview 3.5 Novartis AG, 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification 3.5.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin(2014-2019) 3.5.4 Main Business Overview 3.6 Bristol-Myers Squibb 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification 3.6.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin(2014-2019) 3.6.4 Main Business Overview 3.7 Boehringer Ingelheim GmbH 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification 3.7.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin(2014-2019) 3.7.4 Main Business Overview 3.8 GlaxoSmithKline 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification 3.8.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin(2014-2019) 3.8.4 Main Business Overview 3.9 Albany Molecular Research Inc. 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification 3.9.3 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin(2014-2019) 3.9.4 Main Business Overview 3.10 Bachem Holding AG 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification 3.10.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin(2014-2019) 3.10.4 Main Business Overview 3.11 PCAS 3.12 Patheon N.V. 3.13 AstraZeneca 3.14 Johnson & Johnson 3.15 Merck & Co, Inc. 3.16 BASF SE 3.17 Catalent Inc. 3.18 Teva Pharmaceuticals 3.19 Roche 3.20 Cambrex Corporation 3.21 GILEAD Science Inc. 4 Small Molecule Active Pharmaceutical Ingredient Market Status and Outlook by Regions 4.1 Global Market Status and Outlook by Regions 4.1.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size and CAGR by Regions 4.1.2 North America 4.1.3 Asia-Pacific 4.1.4 Europe 4.1.5 South America 4.1.6 Middle East and Africa 4.2 Global Small Molecule Active Pharmaceutical Ingredient Sales and Revenue by Regions 4.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Regions (2014-2019) 4.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue and Market Share by Regions (2014-2019) 4.2.3 Global Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2014-2019) 4.3 North America Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin 4.3.1 United States 4.3.2 Canada 4.3.3 Mexico 4.4 Europe Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin 4.4.1 Germany 4.4.2 UK 4.4.3 France 4.4.4 Italy 4.4.5 Russia 4.4.6 Turkey 4.5 Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin 4.5.1 China 4.5.2 Japan 4.5.3 Korea 4.5.4 Southeast Asia 4.5.4.1 Indonesia 4.5.4.2 Thailand 4.5.4.3 Malaysia 4.5.4.4 Philippines 4.5.4.5 Vietnam 4.5.5 India 4.5.6 Australia 4.6 South America Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin 4.6.1 Brazil 4.7 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin 4.7.1 Egypt 4.7.2 GCC Countries 5 Small Molecule Active Pharmaceutical Ingredient Application/End Users 5.1 Small Molecule Active Pharmaceutical Ingredient Segment by Application 5.1.1 Cardiovascular Diseases 5.1.2 Respiratory Disorders 5.1.3 Infectious Diseases 5.1.4 Others 5.2 Global Small Molecule Active Pharmaceutical Ingredient Product Segment by Application 5.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Application 5.2.2 Global Small Molecule Active Pharmaceutical Ingredient Sales and Market Share by Application (2014-2019) 6 Global Small Molecule Active Pharmaceutical Ingredient Market Forecast 6.1 Global Small Molecule Active Pharmaceutical Ingredient Sales, Revenue Forecast (2019-2025) 6.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2019-2025) 6.1.1 Global Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2019-2025) 6.2 Global Small Molecule Active Pharmaceutical Ingredient Forecast by Regions 6.2.1 North America Small Molecule Active Pharmaceutical Ingredient Sales and Revenue Forecast (2019-2025) 6.2.2 Europe Small Molecule Active Pharmaceutical Ingredient Sales and Revenue Forecast (2019-2025) 6.2.3 Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Sales and Revenue Forecast (2019-2025) 6.2.3.1 China 6.2.3.2 Japan 6.2.3.3 Korea 6.2.3.4 Southeast Asia 6.2.3.5 India 6.2.3.6 Australia 6.2.4 South America Small Molecule Active Pharmaceutical Ingredient Sales and Revenue Forecast (2019-2025) 6.2.5 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales and Revenue Forecast (2019-2025) 6.2.5.1 Egypt 6.2.5.2 GCC Countries 6.3 Small Molecule Active Pharmaceutical Ingredient Forecast by Type 6.3.1 Global Small Molecule Active Pharmaceutical Ingredient Sales and Revenue Forecast by Type (2019-2025) 6.3.2 Standard API Gowth Forecast 6.3.3 High Potency API Gowth Forecast 6.4 Small Molecule Active Pharmaceutical Ingredient Forecast by Application 6.4.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Application (2019-2025) 6.4.2 Global Small Molecule Active Pharmaceutical Ingredient Forecast in Cardiovascular Diseases 6.4.3 Global Small Molecule Active Pharmaceutical Ingredient Forecast in Respiratory Disorders 7 Small Molecule Active Pharmaceutical Ingredient Upstream Raw Materials 7.1 Small Molecule Active Pharmaceutical Ingredient Key Raw Materials 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price 7.1.3 Raw Materials Key Suppliers 7.2 Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Small Molecule Active Pharmaceutical Ingredient Industrial Chain Analysis 8 Marketing Strategy Analysis, Distributors 8.1 Marketing Channel 8.1.1 Direct Marketing 8.1.2 Indirect Marketing 8.1.3 Marketing Channel Development Trend 8.2 Distributors 8.3 Downstream Customers 9 Research Findings and Conclusion Appendix Methodology/Research Approach Research Programs/Design Market Size Estimation Market Breakdown and Data Triangulation Data Source Secondary Sources Primary Sources Disclaimer

List of Tables and Figures Figure Small Molecule Active Pharmaceutical Ingredient Product Picture Figure Global Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Status and Outlook (2014-2025) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) Status and Outlook (2014-2025) Figure Product Picture of Standard API Table Major Players of Standard API Figure Global Standard API Sales (MT) and Growth Rate (%)(2014-2018) Figure Product Picture of High Potency API Table Major Players of High Potency API Figure Global High Potency API Sales (MT) and Growth Rate (%)(2014-2019) Table Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Comparison by Type Table Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2014-2019) Table Global Small Molecule Active Pharmaceutical Ingredient Sales Share (%) by Type (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) by Type (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) by Type in 2018 Table Global Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) by Type (2014-2019) Table Global Small Molecule Active Pharmaceutical Ingredient Revenue Share (%) by Type (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Revenue Share (%) by Type (2014-2019) Figure 2018 Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) by Type Table Global Small Molecule Active Pharmaceutical Ingredient Price (USD/Kg) by Type (2014-2019) Table Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Company (2014-2019) Table Global Small Molecule Active Pharmaceutical Ingredient Sales Share (%) by Company (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Share (%) by Company in 2018 Table Global Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) by Company (2014-2019) Table Global Small Molecule Active Pharmaceutical Ingredient Revenue Share (%) by Company (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Revenue Share (%) by Company in 2018 Table Global Market Small Molecule Active Pharmaceutical Ingredient Average Price (USD/Kg) by Company (2014-2019) Table Global Small Molecule Active Pharmaceutical Ingredient Top Players Manufacturing Base Distribution and Sales Area Table Global Small Molecule Active Pharmaceutical Ingredient Top Players Product Category Figure Global Small Molecule Active Pharmaceutical Ingredient Market Share (%) of Top 5 Players Figure Global Small Molecule Active Pharmaceutical Ingredient Market Share (%) of Top 10 Players Table Johnson Matthey Basic Information List Table Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification Table Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) Figure Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales Global Market Share (%)(2014-2019) Table Siegfried Holding AG Basic Information List Figure Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification Table Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) Figure Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Global Market Share (%)(2014-2019) Table Pfizer Basic Information List Figure Pfizer Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification Table Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Pfizer Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) Figure Pfizer Small Molecule Active Pharmaceutical Ingredient Sales Global Market Share (%)(2014-2019) Table Sanofi S.A. Basic Information List Figure Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification Table Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) Figure Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales Global Market Share (%)(2014-2019) Table Novartis AG, Basic Information List Figure Novartis AG, Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification Table Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) Figure Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales Global Market Share (%)(2014-2019) Table Bristol-Myers Squibb Basic Information List Figure Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification Table Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) Figure Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales Global Market Share (%)(2014-2019) Table Boehringer Ingelheim GmbH Basic Information List Figure Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification Table Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) Figure Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales Global Market Share (%)(2014-2019) Table GlaxoSmithKline Basic Information List Figure GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification Table GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) Figure GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales Global Market Share (%)(2014-2019) Table Albany Molecular Research Inc. Basic Information List Figure Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification Table Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) Figure Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales Global Market Share (%)(2014-2019) Table Bachem Holding AG Basic Information List Figure Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Product Category, Application and Specification Table Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2014-2019) Figure Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Global Market Share (%)(2014-2019) Table PCAS Basic Information List Table Patheon N.V. Basic Information List Table AstraZeneca Basic Information List Table Johnson & Johnson Basic Information List Table Merck & Co, Inc. Basic Information List Table BASF SE Basic Information List Table Catalent Inc. Basic Information List Table Teva Pharmaceuticals Basic Information List Table Roche Basic Information List Table Cambrex Corporation Basic Information List Table GILEAD Science Inc. Basic Information List Table Global Small Molecule Active Pharmaceutical Ingredient Market Size Comparison by Regions (2014-2025) Figure North America Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Europe Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure South America Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (%)(2014-2025) Table Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Regions (2014-2019) Table Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) by Regions (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) by Regions (2014-2019) Figure 2018 Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) by Regions Table Global Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) by Regions (2014-2019) Table Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) by Regions (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) by Regions (2014-2019) Figure 2018 Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) by Regions Table Global Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure North America Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate Table North America Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure United States Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure United States Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Canada Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Canada Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Mexico Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Mexico Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Europe Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate Table Europe Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Germany Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Germany Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) (2014-2019) Figure UK Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure UK Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure France Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure France Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Italy Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Italy Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Russia Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Russia Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Turkey Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Turkey Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate Table Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure China Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure China Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Japan Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Japan Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Korea Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Korea Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Southeast Asia Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Indonesia Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Indonesia Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Thailand Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Thailand Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Malaysia Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Malaysia Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Philippines Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Philippines Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Vietnam Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Vietnam Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure India Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure India Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Australia Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Australia Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure South America Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate Table South America Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure Brazil Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure Brazil Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate Table Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019) Figure North Africa Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure North Africa Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure GCC Countries Small Molecule Active Pharmaceutical Ingredient Sales (MT)(2014-2019) Figure GCC Countries Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD)(2014-2019) Figure Cardiovascular Diseases Examples Figure Respiratory Disorders Examples Figure Infectious Diseases Examples Figure Others Examples Table Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) Comparison by Application (2014-2025) Table Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2014-2019) Table Global Small Molecule Active Pharmaceutical Ingredient Sales Share (%) by Application (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) by Application (2014-2019) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) by Application in 2018 Figure Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Global Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025) Table Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) Forecast by Regions (2019-2025) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) Forecast by Regions (2019-2025) Figure North America Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure North America Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (%) Forecast (2019-2025) Figure Europe Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Europe Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (%) Forecast (2019-2025) Figure China Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure China Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (%) Forecast (2019-2025) Figure Japan Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Japan Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (%) Forecast (2019-2025) Figure Korea Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Korea Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (%) Forecast (2019-2025) Figure India Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure India Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (%) Forecast (2019-2025) Figure Australia Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Australia Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (%) Forecast (2019-2025) Figure South America Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure South America Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (%) Forecast (2019-2025) Figure North Africa Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure North Africa Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Small Molecule Active Pharmaceutical Ingredient Sales (MT) and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Small Molecule Active Pharmaceutical Ingredient Revenue and Growth Rate (%) Forecast (2019-2025) Table Global Small Molecule Active Pharmaceutical Ingredient Sales (Million USD) Forecast by Type (2019-2025) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share (%) Forecast by Type (2019-2025) Table Global Small Molecule Active Pharmaceutical Ingredient Revenue (Million USD) Forecast by Type (2019-2025) Figure Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share (%) Forecast by Type (2019-2025) Figure Standard API Sales Growth Forecast Figure High Potency API Sales Growth Forecast Table Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) Forecast by Application (2019-2025) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Application (2019-2025) Figure Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) Forecast in Cardiovascular Diseases Figure Global Small Molecule Active Pharmaceutical Ingredient Sales (MT) Forecast in Respiratory Disorders Table Key Raw Materials Lists Figure Key Raw Materials Price Table Raw Materials Key Suppliers Lists Figure Small Molecule Active Pharmaceutical Ingredient Manufacturing Cost Structure Figure Small Molecule Active Pharmaceutical Ingredient Industrial Chain Analysis Table Distributors List Table Small Molecule Active Pharmaceutical Ingredient Downstream Customers

Johnson Matthey Siegfried Holding AG Pfizer Sanofi S.A. Novartis AG, Bristol-Myers Squibb Boehringer Ingelheim GmbH GlaxoSmithKline Albany Molecular Research Inc. Bachem Holding AG PCAS Patheon N.V. AstraZeneca Johnson & Johnson Merck & Co, Inc. BASF SE Catalent Inc. Teva Pharmaceuticals Roche Cambrex Corporation GILEAD Science Inc.